Infliximab is a biologic medication used to treat autoimmune conditions like Crohn’s disease, ulcerative colitis, and rheumatoid arthritis. For treatment to work, the drug must stay at a certain concentration in your bloodstream. While there is no single universal number, most clinical guidelines suggest a target trough level between 3 and 7 µg/mL for inflammatory bowel disease, with levels above 1 µg/mL generally considered the minimum for a measurable response. The exact target depends on your condition, your symptoms, and whether you are taking other medications alongside infliximab.
What Are Infliximab Trough Levels?
Trough level refers to the concentration of infliximab in your blood right before your next infusion. Doctors measure it at this lowest point because it tells them how well the drug holds up between doses. If the level drops too low before the next infusion, the drug may not be active enough to control inflammation.
A blood test is drawn on the day of your infusion, before the medication is given. The results help your doctor decide whether to adjust your dose, shorten the interval between infusions, or switch to a different medication entirely.
What Is the Target Range for Infliximab Levels?
For inflammatory bowel disease, many clinical guidelines recommend a target trough level of 3 to 7 µg/mL. This range is associated with better mucosal healing and fewer disease flares. However, some patients respond well at lower levels, and others need higher levels to achieve remission.
For rheumatoid arthritis and other autoimmune conditions, the evidence for a specific target range is less clear. Some studies suggest a minimum of 1 µg/mL is needed for a clinical response, but optimal levels vary widely between patients. Your doctor will interpret your level in the context of your symptoms and disease activity.
Why Do Infliximab Levels Matter?
Infliximab works by neutralizing tumor necrosis factor-alpha, a protein that drives inflammation in autoimmune diseases. When the drug level is too low, there is not enough medication to block this protein effectively. Inflammation continues, symptoms persist, and the disease can progress silently.
When the level is too high, you may be at greater risk for side effects without additional benefit. The goal is to find the lowest effective level that keeps your disease controlled. This is called personalized dosing, and it is the standard of care in many gastroenterology practices.
What Happens When Infliximab Levels Are Too Low?
Low trough levels are common. They often occur because the body produces antibodies against infliximab. These antibodies bind to the drug and clear it from the bloodstream faster than expected. When this happens, the drug stops working, and symptoms return.
If your level is low and you are experiencing symptoms, your doctor may check for anti-drug antibodies. If antibodies are present at high levels, increasing the dose may not help. In that case, switching to a different biologic may be more effective.
If antibodies are absent or low, your doctor may increase the infliximab dose or shorten the interval between infusions. This approach often restores therapeutic levels and improves symptoms.
What Happens When Infliximab Levels Are Too High?
High trough levels are less common but can occur, especially in patients who are also taking immunosuppressants like azathioprine or methotrexate. These medications reduce the immune response to infliximab, which slows its clearance from the body.
Very high levels are not necessarily harmful, but they do not provide extra benefit. The risk of infection may increase with higher drug exposure, although the evidence for this is not strong. Most clinicians will reduce the dose or extend the interval between infusions if levels are consistently high and the disease is well controlled.
How Are Infliximab Levels Measured?
Infliximab levels are measured using a blood test called an enzyme-linked immunosorbent assay, or ELISA. Some laboratories use a newer test called homogenous mobility shift assay, which may be more accurate in certain situations. Both tests measure the amount of active infliximab in the blood.
Testing is not done routinely for every patient. It is most useful when treatment is not working, when symptoms return after a period of improvement, or when your doctor is considering a dose adjustment. Some clinicians also use it proactively to optimize therapy early in treatment.
What Should Infliximab Levels Be For Effective Treatment?
For most patients with inflammatory bowel disease, the target trough level is 3 to 7 µg/mL. This range is supported by research showing better outcomes for patients who maintain levels within it. Levels above 1 µg/mL are generally considered the minimum for a measurable clinical response.
For other conditions like rheumatoid arthritis, the evidence is less definitive. Some research suggests that levels above 1 µg/mL are associated with better response, but no single target range has been universally accepted. Your doctor will use your level as one piece of information alongside your symptoms, blood markers of inflammation, and imaging results.
It is important to understand that a single trough level does not tell the whole story. Two patients with the same level can have very different outcomes. Your individual disease pattern, prior medication history, and overall health all influence how your body responds to infliximab.
How Often Should Infliximab Levels Be Checked?
There is no standard schedule for checking infliximab levels. Most guidelines recommend testing when there is a clinical reason, such as loss of response, suspected side effects, or before making a major treatment decision. Routine testing in stable patients is not universally recommended, though some specialists do it.
If you are doing well and your disease is in remission, frequent testing is unlikely to change your treatment plan. If you are experiencing symptoms or your doctor is considering a dose change, testing can provide valuable information that guides the next step.
What Factors Affect Infliximab Levels?
Several factors influence how much infliximab stays in your blood between doses. Body weight plays a role, which is why dosing is often based on weight. The presence of anti-drug antibodies is the most important factor that lowers levels.
Concurrent use of immunosuppressants like azathioprine, methotrexate, or 6-mercaptopurine tends to increase infliximab levels by reducing antibody formation. Smoking has been associated with lower drug levels and worse outcomes in some studies. Your individual metabolism also matters, and this can change over time.
Can Infliximab Levels Predict Treatment Success?
Research consistently shows that higher trough levels during the first few months of treatment are associated with better long-term outcomes. Patients who achieve therapeutic levels early are more likely to maintain remission and less likely to need surgery or hospitalization for their disease.
However, the relationship between drug levels and outcomes is not perfect. Some patients with low levels do well, and some with high levels do poorly. This is why doctors do not rely on levels alone. They combine drug levels with clinical assessment to make treatment decisions.
What Should You Ask Your Doctor About Infliximab Levels?
If you are taking infliximab, it is reasonable to ask whether checking your drug level would be helpful. You can ask what your current level is and what the target is for your condition. You can also ask whether anti-drug antibodies have been checked and what the results mean.
If your level is low and you are experiencing symptoms, ask about the options. These may include increasing the dose, shortening the interval between infusions, adding an immunosuppressant, or switching to a different biologic. Each option has its own benefits and risks, and the right choice depends on your specific situation.
Frequently Asked Questions
What is a normal infliximab trough level?
Most clinical guidelines target a trough level of 3 to 7 µg/mL for inflammatory bowel disease, with levels above 1 µg/mL considered the minimum for a response.
Why is my infliximab level low?
Low levels are most often caused by anti-drug antibodies that clear infliximab from your blood faster than normal.
Can infliximab levels be too high?
High levels are not usually harmful, but they do not provide extra benefit and may increase infection risk in some patients.
How long does it take for infliximab levels to become therapeutic?
Most patients reach steady drug levels after the first few doses, typically within 6 to 14 weeks of starting treatment.
